DAFNA Capital Management’s Autolus Therapeutics AUTL Stock Holding History

DAFNA Capital Management’s Portfolio AUTL Stock Details AUTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$287K	Hold	179,316	–	–	0.05%	82
2026 Q1	$247K	Hold	179,316	–	–	0.06%	82
2025 Q4	$357K	Hold	179,316	–	–	0.08%	74
2025 Q3	$292K	Sell	179,316 -246,300	-58%	-$481K	0.07%	73
2025 Q2	$970K	Sell	425,616 -161,051	-27%	-$266K	0.27%	59
2025 Q1	$909K	Hold	586,667	–	–	0.26%	61
2024 Q4	$1.38M	Buy	586,667 +100,000	+21%	+$338K	0.35%	50
2024 Q3	$1.77M	Buy	486,667 +140,000	+40%	+$558K	0.42%	49
2024 Q2	$1.21M	Buy	346,667 +130,000	+60%	+$561K	0.29%	59
2024 Q1	$1.38M	Buy	216,667 +25,597	+13%	+$160K	0.31%	55
2023 Q4	$1.23M	Sell	191,070 -737,183	-79%	-$2.81M	0.29%	57
2023 Q3	$2.16M	Sell	928,253 -2,141	-0.2%	-$6.1K	0.67%	38
2023 Q2	$2.21M	Sell	930,394 -245,756	-21%	-$583K	0.61%	39
2023 Q1	$2.16M	Hold	1,176,150	–	–	0.65%	37
2022 Q4	$2.23M	Buy	1,176,150 +680,000	+137%	+$1.72M	0.63%	43
2022 Q3	$1.06M	Hold	496,150	–	–	0.29%	53
2022 Q2	$1.4M	Hold	496,150	–	–	0.38%	53
2022 Q1	$2.07M	Buy	+496,150	New	+$2.09M	0.54%	47
2020 Q3	–	Sell	-64,235	Closed	-$1.03M	–	81
2020 Q2	$1.03M	Sell	64,235 -155,565	-71%	-$1.73M	0.3%	55
2020 Q1	$1.32M	Buy	219,800 +119,800	+120%	+$1.11M	0.55%	40
2019 Q4	$1.32M	Hold	100,000	–	–	0.45%	51
2019 Q3	$1.24M	Hold	100,000	–	–	0.47%	54
2019 Q2	$1.61M	Buy	+100,000	New	+$2.24M	0.61%	47

Other funds holding AUTL

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

DAFNA Capital Management's AUTL Position: Q2 2026 in Review

DAFNA Capital Management held its Autolus Therapeutics (AUTL) position steady in Q2 2026 at 179,316 shares worth $287K. The position accounts for 0.05% of the portfolio, ranked #82.

DAFNA Capital Management first reported a position in AUTL in Q2 2019 and has held it in 23 quarters since. The position peaked at $2.23M in Q4 2022. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

DAFNA Capital Management held 179,316 shares of Autolus Therapeutics worth $287K as of Q2 2026.
DAFNA Capital Management left its Autolus Therapeutics share count unchanged in Q2 2026.
Autolus Therapeutics made up 0.05% of DAFNA Capital Management's portfolio in Q2 2026, its #82 holding.
DAFNA Capital Management first reported a position in Autolus Therapeutics in Q2 2019 and has held it in 23 quarters since.
DAFNA Capital Management's Autolus Therapeutics position peaked at $2.23M in Q4 2022.
84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on DAFNA Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.